Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg '"''

Voglibose 0.3 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg
VOGLIGOLD G3 M0.3  
Voglibose is an alpha-glucosidase inhibitor. It works by slowing down the digestion and absorption of carbohydrates in the intestines, which helps prevent rapid spikes in blood sugar after meals.
Voglibose is primarily used to improve postprandial (after-meal) blood sugar control in people with type 2 diabetes. Glimepiride is a sulfonylurea medication. It stimulates the pancreas to release insulin, which helps lower blood sugar levels by increasing the uptake of glucose by cells.
Glimepiride is used to lower fasting and postprandial blood sugar levels in individuals with type 2 diabetes.  
Metformin is a biguanide medication. It primarily reduces blood sugar levels by decreasing the production of glucose in the liver and improving the sensitivity of cells to insulin, making it easier for cells to take in glucose.
Metformin is commonly used as a first-line treatment for type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/vogligold-g3-m0-3-134319